Evidence map›Paper›PMID 28541639›Full record

ArticleJournal of gynecologic oncology2017

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.

Mikio Mikami, Satoru Nagase, Wataru Yamagami, Kimio Ushijma, Hironori Tashiro, Hidetaka Katabuchi, Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology (JSOG)

Open access · diamondAbstract read
In one paragraph

Article in Journal of gynecologic oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Mikio MikamiDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan. mmikami@is.icc.u-tokai.ac.jp.ORCID https://orcid.org/0000-0002-7496-3518
Satoru NagaseDepartment of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan.
Wataru YamagamiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-3925-6057
Kimio UshijmaDepartment of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.ORCID https://orcid.org/0000-0002-6087-8873
Hironori TashiroDepartment of Obstetrics and Gynecology, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-6236-2849
Hidetaka KatabuchiDepartment of Obstetrics and Gynecology, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.ORCID https://orcid.org/0000-0002-2403-6134
Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology (JSOG)
Kumamoto University · JPKeio University · JPKurume University · JPTokai University · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRecent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention.

methodsWe mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist.

resultsAmong the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer.

conclusionThe JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.

Indexed as

GynecologyObstetricsSocieties, MedicalAccreditationCarcinoma, Ovarian EpithelialElective Surgical ProceduresFemaleGenital Diseases, FemaleHospitals, TeachingHumansJapanNeoplasms, Glandular and EpithelialOvarian NeoplasmsRandomized Controlled Trials as TopicSalpingectomySurveys and QuestionnairesOvarian NeoplasmsPrevention & ControlSalpingectomy

Identifiers

PMID28541639
PMCPMC5447150
OpenAlexW2612702610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.